Format

Send to

Choose Destination
Chin J Cancer. 2017 Nov 21;36(1):92. doi: 10.1186/s40880-017-0258-8.

International Szent-Györgyi Prize for Progress in Cancer Research: basic and translational research recognition : Mary-Claire King received the 2016 Prize for her pioneering research that demonstrated the first evidence of genetic predisposition to breast cancer.

Author information

1
National Foundation for Cancer Research, 4600 East West Highway, Suite 525, Bethesda, MD, 20814, USA. hhartmann@nfcr.org.
2
National Foundation for Cancer Research, 4600 East West Highway, Suite 525, Bethesda, MD, 20814, USA.

Abstract

The Szent-Györgyi Prize for Progress in Cancer Research is a prestigious scientific award sponsored by the National Foundation for Cancer Research (NFCR)-a leading cancer research charitable organization in the United States that supports innovative cancer research globally with the ultimate goal to cure cancer. The coveted Szent-Györgyi Prize annually honors a scientist whose seminal discovery or body of work has resulted in, or led toward, notable contributions to cancer prevention, diagnosis, or treatment; and the discovery has had a high direct impact of saving people's lives. In addition, the prize promotes public awareness of the importance of basic cancer research and encourages the sustained investment needed to accelerate the translation of these research discoveries into new cancer treatments. In 2016, NFCR's Szent-Györgyi Prize Selection Committee was unanimous in its decision to recognize an icon in human disease genetics, Dr. Mary-Claire King, for her pioneering research that demonstrated the first evidence of genetic predisposition to breast cancer. Her proof of existence of BRCA1 gene and its location has made genetic screening for breast and ovarian cancers possible, saving lives of many people who are at high risk with inherited BRCA1 mutations.

KEYWORDS:

BRCA1 and genetic testing; Mary-Claire King; The National Foundation for Cancer Research; The Szent-Györgyi Prize

PMID:
29162161
PMCID:
PMC5697018
DOI:
10.1186/s40880-017-0258-8
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for BioMed Central Icon for PubMed Central
Loading ...
Support Center